|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sher T, Dy GK and Adjei AA: Small cell
lung cancer. Mayo Clin Proc. 83:355–367. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pelayo Alvarez M, Westeel V, Cortés-Jofré
M and Bonfill Cosp X: Chemotherapy versus best supportive care for
extensive small cell lung cancer. Cochrane Database Syst Rev.
11:CD0019902013.PubMed/NCBI
|
|
4
|
Lally BE, Urbanic JJ, Blackstock AW,
Miller AA and Perry MC: Small cell lung cancer: Have we made any
progress over the last 25 years? Oncologist. 12:1096–1104. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tyler A, Johansson A, Karlsson T, Gudey
SK, Brännström T, Grankvist K and Behnam-Motlagh P: Targeting
glucosylceramide synthase induction of cell surface
globotriaosylceramide (Gb3) in acquired cisplatin-resistance of
lung cancer and malignant pleural mesothelioma cells. Exp Cell Res.
336:23–32. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kang J and Pervaiz S: Mitochondria: Redox
metabolism and dysfunction. Biochem Res Int. 2012:8967512012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Slater AF, Stefan C, Nobel I, van den
Dobbelsteen DJ and Orrenius S: Signalling mechanisms and oxidative
stress in apoptosis. Toxicol Lett. 82–83:149–153. 1995. View Article : Google Scholar
|
|
8
|
Matés JM, Segura JA, Alonso FJ and Márquez
J: Oxidative stress in apoptosis and cancer: An update. Arch
Toxicol. 86:1649–1665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kroemer G and Blomgren K: Mitochondrial
cell death control in familial Parkinson disease. PLoS Biol.
5:e2062007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoboue ED and Devin A: Reactive oxygen
species-mediated control of mitochondrial biogenesis. Int J Cell
Biol. 2012:4038702012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fruehauf JP and Meyskens FL Jr: Reactive
oxygen species: A breath of life or death? Clin Cancer Res.
13:789–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shahrzad S, Aoyagi K, Winter A, Koyama A
and Bitsch I: Pharmacokinetics of gallic acid and its relative
bioavailability from tea in healthy humans. J Nutr. 131:1207–1210.
2001.PubMed/NCBI
|
|
13
|
Oi Y, Hou IC, Fujita H and Yazawa K:
Antiobesity effects of Chinese black tea (Pu-erh tea) extract and
gallic acid. Phytother Res. 26:475–481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsiang CY, Hseu YC, Chang YC, Kumar KJ, Ho
TY and Yang HL: Toona sinensis and its major bioactive compound
gallic acid inhibit LPS-induced inflammation in nuclear factor-κB
transgenic mice as evaluated by in vivo bioluminescence imaging.
Food Chem. 136:426–434. 2013. View Article : Google Scholar
|
|
15
|
Chuang CY, Liu HC, Wu LC, Chen CY, Chang
JT and Hsu SL: Gallic acid induces apoptosis of lung fibroblasts
via a reactive oxygen species-dependent ataxia telangiectasia
mutated-p53 activation pathway. J Agric Food Chem. 58:2943–2951.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
You BR and Park WH: The effects of
mitogen-activated protein kinase inhibitors or small interfering
RNAs on gallic acid-induced HeLa cell death in relation to reactive
oxygen species and glutathione. J Agric Food Chem. 59:763–771.
2011. View Article : Google Scholar
|
|
17
|
You BR, Kim SZ, Kim SH and Park WH: Gallic
acid-induced lung cancer cell death is accompanied by ROS increase
and glutathione depletion. Mol Cell Biochem. 357:295–303. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chia YC, Rajbanshi R, Calhoun C and Chiu
RH: Anti-neoplastic effects of gallic acid, a major component of
Toona sinensis leaf extract, on oral squamous carcinoma cells.
Molecules. 15:8377–8389. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Russell LH Jr, Mazzio E, Badisa RB, Zhu
ZP, Agharahimi M, Oriaku ET and Goodman CB: Autoxidation of gallic
acid induces ROS-dependent death in human prostate cancer LNCaP
cells. Anticancer Res. 32:1595–1602. 2012.PubMed/NCBI
|
|
20
|
Govindan R, Page N, Morgensztern D, Read
W, Tierney R, Vlahiotis A, Spitznagel EL and Piccirillo J: Changing
epidemiology of small-cell lung cancer in the United States over
the last 30 years: Analysis of the surveillance, epidemiologic, and
end results database. J Clin Oncol. 24:4539–4544. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schiller JH: Small cell lung cancer:
Defining a role for emerging platinum drugs. Oncology. 63:105–114.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bayet-Robert M, Kwiatkowski F, Leheurteur
M, Gachon F, Planchat E, Abrial C, Mouret-Reynier MA, Durando X,
Barthomeuf C and Chollet P: Phase I dose escalation trial of
docetaxel plus curcumin in patients with advanced and metastatic
breast cancer. Cancer Biol Ther. 9:8–14. 2010. View Article : Google Scholar
|
|
23
|
Kasibhatla S and Tseng B: Why target
apoptosis in cancer treatment? Mol Cancer Ther. 2:573–580.
2003.PubMed/NCBI
|
|
24
|
Singh BN, Shankar S and Srivastava RK:
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms,
perspectives and clinical applications. Biochem Pharmacol.
82:1807–1821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fiers W, Beyaert R, Declercq W and
Vandenabeele P: More than one way to die: Apoptosis, necrosis and
reactive oxygen damage. Oncogene. 18:7719–7730. 1999. View Article : Google Scholar
|
|
26
|
Ma Y, Zhang J, Zhang Q, Chen P, Song J, Yu
S, Liu H, Liu F, Song C, Yang D, et al: Adenosine induces apoptosis
in human liver cancer cells through ROS production and
mitochondrial dysfunction. Biochem Biophys Res Commun. 448:8–14.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lotem J and Sachs L: Regulation of bcl-2,
bcl-XL and bax in the control of apoptosis by
hematopoietic cytokines and dexamethasone. Cell Growth Differ.
6:647–653. 1995.PubMed/NCBI
|
|
28
|
Chen Q, Liu XF and Zheng PS: Grape seed
proanthocyanidins (GSPs) inhibit the growth of cervical cancer by
inducing apoptosis mediated by the mitochondrial pathway. PLoS One.
9:e1070452014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Verhagen AM, Ekert PG, Pakusch M, Silke J,
Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL:
Identification of DIABLO, a mammalian protein that promotes
apoptosis by binding to and antagonizing IAP proteins. Cell.
102:43–53. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang L, Wang P, Wang H, Li Q, Teng H, Liu
Z, Yang W, Hou L and Zou X: Fucoidan derived from Undaria
pinnatifida induces apoptosis in human hepatocellular carcinoma
SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar
Drugs. 11:1961–1976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Qin CK, Lv W, Zhao Q and Qin CY:
OSU-03012, a non-Cox inhibiting celecoxib derivative, induces
apoptosis of human esophageal carcinoma cells through a
p53/Bax/cytochrome c/caspase-9-dependent pathway. Anticancer Drugs.
24:690–698. 2013. View Article : Google Scholar : PubMed/NCBI
|
